Dmitry Balyasny’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.1M Buy
463,163
+369,708
+396% +$34.8M 0.05% 412
2026
Q1
$8.31M Buy
93,455
+90,043
+2,639% +$9.25M 0.01% 1118
2025
Q4
$325K Buy
+3,412
New +$344K ﹤0.01% 2699
2025
Q2
Sell
-37,756
Closed -$3.44M 2848
2025
Q1
$3.44M Buy
+37,756
New +$4.23M 0.01% 1433
2024
Q4
Sell
-620,466
Closed -$73.7M 2758
2024
Q3
$73.7M Buy
620,466
+164,548
+36% +$15.1M 0.12% 187
2024
Q2
$36.6M Buy
455,918
+265,816
+140% +$24.3M 0.06% 385
2024
Q1
$17.5M Buy
+190,102
New +$18.2M 0.03% 674
2023
Q4
Sell
-348,728
Closed -$37.9M 2509
2023
Q3
$37.9M Buy
348,728
+195,104
+127% +$21.6M 0.08% 353
2023
Q2
$16.6M Buy
+153,624
New +$17.3M 0.04% 593
2023
Q1
Sell
-113,528
Closed -$17.1M 2671
2022
Q4
$17.1M Buy
113,528
+105,691
+1,349% +$16.3M 0.05% 545
2022
Q3
$1.06M Buy
7,837
+2,864
+58% +$438K ﹤0.01% 1771
2022
Q2
$741K Sell
4,973
-103,495
-95% -$15.8M ﹤0.01% 1864
2022
Q1
$18.5M Buy
+108,468
New +$18.2M 0.06% 444
2021
Q4
Sell
-38,455
Closed -$10.5M 2253
2021
Q3
$10.5M Buy
+38,455
New +$12.2M 0.04% 555
2020
Q4
Sell
-181,619
Closed -$17.8M 1343
2020
Q3
$12.6M Sell
181,619
-34,166
-16% -$2.45M 0.09% 323
2020
Q2
$14.4M Buy
+215,785
New +$10.8M 0.12% 248

Other funds holding BNTX

Dmitry Balyasny's BNTX Position: Q2 2026 in Review

Dmitry Balyasny increased its BioNTech (BNTX) stake by 396% in Q2 2026, buying an estimated $34.8M and bringing the position to 463,163 shares worth $43.1M. The position accounts for 0.05% of the portfolio, ranked #412.

Dmitry Balyasny first reported a position in BNTX in Q2 2020 and has held it in 16 quarters since. The position peaked at $73.7M in Q3 2024. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Dmitry Balyasny held 463,163 shares of BioNTech worth $43.1M as of Q2 2026.
  • Dmitry Balyasny bought 369,708 BioNTech shares in Q2 2026, an estimated $34.8M.
  • BioNTech made up 0.05% of Dmitry Balyasny's portfolio in Q2 2026, its #412 holding.
  • Dmitry Balyasny first reported a position in BioNTech in Q2 2020 and has held it in 16 quarters since.
  • Dmitry Balyasny's BioNTech position peaked at $73.7M in Q3 2024.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.